Health Care Disparities Between Men and Women With T2DM Health Care Disparities Between Men and Women With T2DM
How does gender impact the use of health care services by persons with type 2 diabetes?Preventing Chronic Disease
AbstractPurposeSleep problems are very common in people with diabetes. The aim of this study was to assess the association of the combination of self-reported sleep duration and sleep quality on quality of life (QOL) in Chinese patients with type 2 diabetes mellitus (T2DM).MethodsWe analyzed the community-based cross-sectional data of 798 patients with T2DM in Xiamen, China, in 2016. Sleep duration was measured as self-reported average sleep time during the previous month. Sleep quality was evaluated as self-rated reports. QOL was assessed by the Diabetes-specific Quality of Life (DSQL), with scores
Authors: Gómez-Sámano MÁ, Almeda-Valdes P, Cuevas-Ramos D, Navarro-Flores MF, Espinosa-Salazar HD, Martínez-Saavedra M, León-Domínguez JA, Enríquez-Estrada VM, López-González AL, Sarmiento-Moreno AL, Rivera-González LA, Juárez-León ÓA, Pérez-González B, Ávila-Palacios Y, Sigala-Pedroza L, Huerta-Ávila E, Vargas-Álvarez MA, Sánchez-Jaimes C, Cárdenas-Vera M, Mehta R, López-Flores A La Torre MA, Manjarrez-Martínez I, Brito-Córdova GX, Zuarth-Vázquez JM, Vega-B...
DIABETES type 2 risk could be lowered by making some diet or lifestyle changes. Adding these five diabetes “superfoods” could help to lower the risk of high blood sugar symptoms. Are you at risk of developing diabetes signs?
ConclusionREHIT may offer a genuinely time-efficient exercise option for improving 24-h glycaemia in men with type 2 diabetes and warrants further study.
EMPA-HEART Cardiolink-6 trial results suggest that the SGLT2 inhibitor is linked to reduced left ventricular mass, a surrogate for reduced heart failure, in patients with CVD and type 2 diabetes.Medscape Medical News
TUESDAY, Nov. 13, 2018 -- Treatment with dapagliflozin is noninferior to placebo for major adverse cardiovascular events (MACE) among patients with type 2 diabetes with or at risk for atherosclerotic cardiovascular disease, according to a study...
BRIDGEWATER, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,wearable insulin delivery option for patients with diabetes, announced today a poster titled“Relationship between Baseline BMI and Clinical Outcomes with V-Go® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes Previously Prescribed Basal-Bolus Regimens”...This story is related to the following:Medical Devices
TYPE 2 diabetes can be controlled by eating the right kind of diet and cutting down on foods that are high in sugar, fat and salt. If you have diabetes but love cheese, try replacing your regular choice with this type to keep the condition under control.
Rodrigo S. Delevatti, Ana Carolina Kanitz, Cristine L. Alberton, Elisa Corr êa Marson, Patricia Dias Pantoja, Carolina DertzbocherFeil Pinho, Salime Chedid Lisboa, Luiz Fernando M. Kruel